Schwartz Aharon
- SEC CIK
- 0001625184
No open-market purchases or sales filed in the past year.
Current role at each company
- PLX Protalix BioTherapeutics, Inc.Directoras of Sep 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schwartz Aharon as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 (view filing) | Jun 10 | 63 daysLate | Schwartz AharonDirector | PPurchase | +129.0K | $1.60 | +$206.4K | +74.1%303.0K after | |
| Jan 5, 2023 (view filing) | Jan 3 | 2 days | Schwartz AharonDirector | PPurchase | +110.0K | $1.42 | +$156.2K | +171.9%174.0K after |